Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2376175
Max Phase: Preclinical
Molecular Formula: C33H50O5
Molecular Weight: 526.76
Molecule Type: Small molecule
Associated Items:
ID: ALA2376175
Max Phase: Preclinical
Molecular Formula: C33H50O5
Molecular Weight: 526.76
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COC(=O)[C@@]1(C)CC[C@]2(C)CC[C@]3(C)C(=CC(=O)[C@@H]4[C@@]5(C)CC[C@H](OC(C)=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1
Standard InChI: InChI=1S/C33H50O5/c1-20(34)38-25-11-12-31(6)24(28(25,2)3)10-13-33(8)26(31)23(35)18-21-22-19-30(5,27(36)37-9)15-14-29(22,4)16-17-32(21,33)7/h18,22,24-26H,10-17,19H2,1-9H3/t22-,24-,25-,26+,29+,30-,31-,32+,33+/m0/s1
Standard InChI Key: SQKQLNBOGMDCIC-IREBYWSLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 526.76 | Molecular Weight (Monoisotopic): 526.3658 | AlogP: 7.07 | #Rotatable Bonds: 2 |
Polar Surface Area: 69.67 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 6.62 | CX LogD: 6.62 |
Aromatic Rings: 0 | Heavy Atoms: 38 | QED Weighted: 0.36 | Np Likeness Score: 2.99 |
1. Kalani K, Kushwaha V, Verma R, Murthy PK, Srivastava SK.. (2013) Glycyrrhetinic acid and its analogs: a new class of antifilarial agents., 23 (9): [PMID:23541646] [10.1016/j.bmcl.2013.02.115] |
2. Csuk R, Siewert B, Wiemann J.. (2013) A bioassay-driven discovery of an unexpected selenophene and its cytotoxicity., 23 (12): [PMID:23664875] [10.1016/j.bmcl.2013.04.036] |
Source(1):